Optimizing the treatment of type 2 diabetes using current and future insulin technologies.
Good glycemic control is crucial to improving outcomes in both surgical and non-surgical patients with type 2 diabetes. New developments in insulin treatment and delivery devices can help to achieve and maintain blood glucose targets.
Boyle
Mary E
ME
Department of Endocrinology, Mayo Clinic Arizona, Scottsdale, AZ, USA.
D002648:Child; D002755:Choice Behavior; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism / Q000451:nursing; D005544:Forecasting; D006442:Glycated Hemoglobin / Q000032:analysis / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000600:supply & distribution / Q000627:therapeutic use*; D015918:Infusion Pumps, Implantable; D007277:Injections, Jet; D007279:Injections, Subcutaneous; D007328:Insulin / Q000031:analogs & derivatives / Q000600:supply & distribution / Q000627:therapeutic use*; D007332:Insulin Infusion Systems; D008875:Middle Aged; D024802:Nurse's Role; D010342:Patient Acceptance of Health Care; D010353:Patient Education as Topic; D017410:Practice Guidelines as Topic; D013594:Syringes; D013997:Time Factors
D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin